AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,000 | 0.0% | 233 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $2,000 | -77.8% | 233 | -60.2% | 0.00% | -75.0% |
| Q4 2017 | $9,000 | -25.0% | 585 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $12,000 | +33.3% | 585 | -0.2% | 0.01% | +20.0% |
| Q2 2017 | $9,000 | +80.0% | 586 | -0.5% | 0.01% | +66.7% |
| Q1 2017 | $5,000 | +400.0% | 589 | +645.6% | 0.00% | – |
| Q4 2016 | $1,000 | -83.3% | 79 | -87.9% | 0.00% | -100.0% |
| Q3 2016 | $6,000 | 0.0% | 652 | -6.9% | 0.00% | 0.0% |
| Q2 2016 | $6,000 | -14.3% | 700 | 0.0% | 0.00% | -20.0% |
| Q1 2016 | $7,000 | -22.2% | 700 | +12.7% | 0.01% | -16.7% |
| Q4 2015 | $9,000 | – | 621 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |